Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Bicycle Therapeutics plc
IPO Date: May 20, 2019
Sector: Healthcare
Industry: Biotech
Market Cap: $595.58M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.65 | 3.02%
Avg Daily Range (30 D): $0.30 | 3.82%
Avg Daily Range (90 D): $0.30 | 3.02%
Institutional Daily Volume
Avg Daily Volume: .2M
Avg Daily Volume (30 D): .38M
Avg Daily Volume (90 D): .29M
Trade Size
Avg Trade Size (Sh.): 94
Avg Trade Size (Sh.) (30 D): 97
Avg Trade Size (Sh.) (90 D): 87
Institutional Trades
Total Inst.Trades: 1,045
Avg Inst. Trade: $2.05M
Avg Inst. Trade (30 D): $1.2M
Avg Inst. Trade (90 D): $2.13M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $1.19M
Avg Closing Trade (30 D): $.52M
Avg Closing Trade (90 D): $.56M
Avg Closing Volume: 45.28K
       
News
Mar 3, 2025 @ 6:00 PM
Advanced Urothelial Carcinoma Clinical Trial Pipel...
Source: Delveinsight
Jun 27, 2024 @ 1:40 PM
Are Medical Stocks Lagging Bicycle Therapeutics (...
Source: Zacks Equity Research
Jun 21, 2024 @ 12:24 PM
Top 5 Small-Cap Biotechnology Stocks for a Stable ...
Source: Nalak Das
Jun 11, 2024 @ 1:40 PM
Is Bicycle Therapeutics (BCYC) Stock Outpacing Its...
Source: Zacks Equity Research
May 24, 2024 @ 4:25 PM
Bicycle Therapeutics (BCYC) Up as PIPE Funding Set...
Source: Zacks Equity Research
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $-3.14 $-.88 $-.75
Diluted EPS $-3.14 $-.88 $-.75
Revenue $ 25.72M $ 9.98M $ 3.71M
Gross Profit $ $ $
Net Income / Loss $ -203.22M $ -60.75M $ -51.85M
Operating Income / Loss $ -248.36M $ -70.2M $ -67.66M
Cost of Revenue $ $ $
Net Cash Flow $ 335.79M $ -87.02M $ -9.56M
PE Ratio